Global Dengue Vaccine Market (2017-2022): Analysis By Vaccine Type & End User - Research and Markets

DUBLIN--()--The "Global Dengue Vaccine Market Analysis 2017 - Forecast to 2022" report has been added to Research and Markets' offering.

The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Dengue Vaccine". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America).

This report provides:

  • Market sizing estimations and forecasts for 6 years across the given market segments.
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities).
  • Strategic recommendations in key business segments based on the market estimations.
  • Regional and country level market analysis.
  • Competitive landscaping of major market players.
  • Company profiling covering the financials, recent activities and the future strategies.

Companies Mentioned

  • Biological E. Limited
  • GlaxoSmithKline plc
  • Instituto Butantan (Brezil)
  • Merck & Co Pharmaceutical company Ltd
  • Panacea Biotech Ltd
  • Sanofi Pasteur
  • Sun Pharmaceutical Industries
  • Takeda Pharmaceutical company Ltd
  • U.S NIH
  • Vabiotec (Vietnam)

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Dengue Vaccine Market by Vaccine Type

6 Dengue Vaccine Market by End User

7 Geographical Segmentation

8 Vendor Landscaping

9 Company Profiles

10 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/h2pcfq/global_dengue

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Vaccines